Design and fabrication of 3D porous scaffolds to facilitate cell-based gene therapy

Tissue Engineering - Part A.

Volumn 14, Issue 6, 2008, Pages 1037-1048

  El Ayoubi, Rouwayda ^a   Eliopoulos, Nicoletta ^b   Diraddo, Robert ^a   Galipeau, Jacques ^b   Yousefi, Azizeh Mitra ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARCHITECTURAL DESIGN; BIOLOGICAL MATERIALS; BIOMATERIALS; CELL CULTURE; CELL PROLIFERATION; CELLS; CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DRUG DELIVERY; DRUG DOSAGE; DRUG THERAPY; GENE TRANSFER; GENETIC ENGINEERING; HEALTH; LEACHING; MICROPOROSITY; OXYGEN; PORE SIZE; POROSITY; SIZE DISTRIBUTION; THREE DIMENSIONAL; TISSUE;

BIMODAL PORE SIZE DISTRIBUTION; BONE MARROW (BM); CELL-BASED; CELL-VIABILITY; CONCENTRATION (COMPOSITION); DELIVERY SYSTEMS; EMBEDDED CELLS; ERYTHROPOIETIN (EPO); GENE DELIVERY; GENE PRODUCTS; GENE THERAPIES; IN-CELL; MACROPOROUS; MESENCHYMAL STROMAL CELLS; METABOLIC ACTIVITIES; OXYGEN DIFFUSION; POLY L LACTIDE (PLLA); POROGEN LEACHING; POROUS SCAFFOLDS; SOLID FREE FORM FABRICATION (SFFF); SUPERNATANTS; THREE-DIMENSIONAL (3D) SCAFFOLDS; TISSUE REGENERATION;

SCAFFOLDS;

ERYTHROPOIETIN; POLYLACTIDE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL BASED GENE THERAPY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE DELIVERY SYSTEM; LEACHING; MESENCHYME CELL; MOUSE; NONHUMAN; POROSITY; PRIORITY JOURNAL; STROMA CELL;

MURINAE;

EID: 45749091716     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2006.0418     Document Type: Article

References (68)

1. Chang, P.L., and Bowie, K.M. Development of engineered cells for implantation in gene therapy. Adv Drug Deliv Rev 33, 31, 1998.
2. Razaq, S., Wilkins, R.J., and Urban, J.P.G. The effect of extracellular pH on matrix turnover by cells of the bovine nucleus pulposus. Eur Spine J 12, 341, 2003.
3. Bibby, S.R.S., and Urban, J.P.G. Effect of nutrient deprivation on the viability of intervertebral disc cells. Eur Spine J 13, 695, 2004.
4. Jelkmann, W., and Metzen, E. Erythropoietin in the control of red cell production. Ann Anat 178, 391, 1996.
5. Gerson, S.L. Mesenchymal stem cells: no longer second class marrow citizens. Nat Med 5, 262, 1999.
6. Caplan, A.I., and Bruder, S.P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century [Review]. Trends Mol Med 7, 259, 2001.
7. Horwitz, E.M. Stem cell plasticity: the growing potential of cellular therapy [Review]. Arch Med Res 34, 600, 2003.
8. Pochampally, R.R., Horwitz, E.M., DiGirolamo, C.D., Stokes, D.S., and Prockop, D.J. Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects. Gene Ther 12, 1119, 2005.
9. Eliopoulos, N., Al-Khaldi, A., Crosato, M., Lachapelle, K., and Galipeau, J. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice. Gene Ther 10, 478, 2003.
10. Eliopoulos, N., Lejeune, L., Martineau, D., and Galipeau, J. Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells. Mol Ther 10, 741, 2004.
11. Eliopoulos, N., Gagnon, R.F., Francois, M., and Galipeau, J. Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure. J Am Soc Nephrol 17, 1576, 2006.
12. Mooney, D.J., Sano, K., Kaufmann, P.M., Majahod, K., Schloo, B., Vacanti, J.P., and Langer, R. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res 37, 413, 1997.
13. Hurtado, A., Moon, L.D., Maquet, V., Blits, B., Jérõme, R., and Oudega, M. Poly (D,L-lactic acid) macroporous guidance scaffolds seeded with Schwann cells genetically modified to secrete a bi-functional neurotrophin implanted in the completely transected adult rat thoracic spinal cord. Biomaterials 27, 430, 2006.
14. Hutmacher, D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 21, 2529, 2000.
15. Vacanti, J.P., and Langer, R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 354, SI32, 1999.
16. Landers, R., Pfister, A., Hubner, U., John, H., Schmelzeisen, R., and Mullhaupt, R. Fabrication of soft tissue engineering scaffolds by means of rapid prototyping techniques. J Mater Sci 37, 3107, 2002.
17. Taboas, J.M., Maddox, R.D., Krebsbach, P.H., and Hollister, S.J. Indirect solid free form fabrication of local and global porous, biomimetic and composite 3D polymer-ceramic scaffolds. Biomaterials 24, 181, 2003.
18. Weiss, L. Process overview. Analytical chapters NSF sponsored JTEC/WTEC panel report on rapid prototyping in Europe and Japan. International Technology Research Institute at Loyola College 5, 5, 1997.
19. Moroni, L., de Wijn, J.R., and van Blitterswijk, C.A. 3D fiber-deposited scaffolds for tissue engineering: influence of pores geometry and architecture on dynamic mechanical properties. Biomaterials 27, 974, 2006.
20. Pfister, A., Landers, R., Laib, A., Hübner, U., Schmelzeisen, R., and Mülhaupt, R. Biofunctional rapid prototyping for tissue-engineering applications: 3D bioplotting versus 3D printing. J Polym Sci [A1] 42, 624, 2004.
21. Kim, S.S., Utsunomiya, H., Koski, J.A., Wu, B.M., Cima, M.J., Sohn, J., Mukai, K., Griffith, L.G., and Vacanti, J.P. Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg 228, 8, 1998.
22. Khademhosseini, A., Langer, R., Borenstein, J., and Vacanti, J.P. Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci USA 103, 2480, 2006.
23. Yousefi, A.M., Gauvin, C., Sun, L., DiRaddo, R.W., and Fernandes, J. Design and fabrication of 3D-plotted polymeric scaffolds in functional tissue engineering. Polym Eng Sci 47, 608, 2007.
24. Dealy, J.M., and Wissbrun, K.F. Melt Rheology and Its Role in Plastics Processing. New York: Van Nostrand Reinhold Press, 1990.
25. Kim, S.Y., Choi, D.G., and Yang, S.M. Rheological analysis of the gelation behavior of tetraethylorthosilane/ vinyltriethoxysilane hybrid solutions. Korean J Chem Eng 19, 190, 2002.
26. Regulier, E., Schneider, B.L., Deglon, N., Beuzard, Y., and Aebischer, P. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts. Gene Ther 5, 1014, 1998.
27. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55, 1983.
28. Ferry, J.D. Viscoelastic Properties of Polymers. New York: John Wiley & Sons, 1980.
29. Bursac, P.M., Obitz, T.W., Eisenberg, S.R., and Stamenovic, D. Confined and unconfined stress relaxation of cartilage: appropriateness of a transversely isotropic analysis. J Biomech 32, 1125, 1999.
30. Woodfield, T.B.F., van Blitterswijk, C.A., de Wijn, J., Sims, T.J., Hollander, A.P., and Riesle J. Within tissue-engineered cartilage constructs. Tissue Eng 11, 1297, 2005.
31. Schugens, C., Maquet, V., Grandfils, C., Jérõme, R., and Teyssie, P. Polylactide macroporous biodegradable implants for cell transplantation: II. Preparation of polylactide foams by liquid-liquid phase separation. J Biomed Mater Res 30, 449 1996.
32. Nam, Y.S., and Park, T.G. Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. J Biomed Mater Res 47, 8, 1999.
33. Whang, K., Thomas, C.H., and Healy, K.E. A novel method to fabricate biodegradable scaffolds. Polymer 36, 837, 1995.
34. Mooney, D.J., Baldwin, D.F., Suh, N.P., Vacanti, J.P., and Langer, R. Novel approach to fabricate porous sponges of poly (D,L-lactic-co- glycolic acid) without the use of organic solvents. Biomaterials 17, 1417, 1996.
35. Mikos, A.G., Bao, Y., Cima, L.G., Ingber, D.E., Vacanti, J.P., and Langer, R. Preparation of poly (glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res 27, 183, 1993.
36. Mikos, A.G., Thorsen, A.J., Czerwonka, L.A., Bao, Y., Langer, R., Winslow, D.N., and Vacanti, J.P. Preparation and characterization of poly (L-lactic acid) foams. Polymer 35, 1069, 1994.
37. Murphy, W.L., Dennis, R.G., Kilney, J.L., and Mooney, D.J. Salt fusion: an approach to improve pore interconnectivity within tissue engineering scaffolds. Tissue Eng 8, 43, 2002.
38. Leong, K.F., Cheah, C.M., and Chua, C.K. Solid free-form fabrication of three-dimensional scaffolds for engineering replacement tissues and organs. Biomaterials 24, 2363, 2003.
39. Rose, F.R., Cyster, L.A., Grant, D.M., Scotchford, C.A., Howdle, S.M., and Shakesheff, K.M. In vitro assessment of cell penetration into porous hydroxyapatite scaffolds with a central aligned channel. Biomaterials 25, 5507, 2004.
40. Sakai, Y., Otsuka, M., Hanada, S., Nishiyama, Y., Konishi, Y., and Yamashita, A. A novel poly-L-lactic acid scaffold that possesses a macroporous structure and a branching/joining three-dimensional flow channel network: its fabrication and application to perfusion culture of human hepatoma Hep G2 cells. Mater Sci Eng C 24, 379, 2004.
41. Mahoney, M.J., Chen, R.R., Tan, J., and Saltzman, W.M. The influence of microchannels on neurite growth and architecture. Biomaterials 26, 771, 2005.
42. Blokhuis, T.J.M.D., Termaat, M.F.M.D., den Boer, F.C.M.D., Patka, P.M.D.P., Bakker, F.C.M.D.P., and Haarman, H.J.T.M.M.D. Properties of calcium phosphate ceramics in relation to their in vivo behavior. J Traum Inj Inf Crit Care 48, 179, 2000.
43. Freyman, T.M., Yannas, I.V., and Gibson, L.J. Cellular materials as porous scaffolds for tissue engineering. Prog Mater Sci 46, 273, 2001.
44. Gao, J., Crapo, P.M., and Wang, Y. Macroporous elastomeric scaffolds with extensive micropores for soft tissue engineering. Tissue Eng 12, 917, 2006.
45. Ranucci, C.S., and Moghe, O.V. Polymer substrate topography actively regulates the multicellular organization and liverspecific functions of cultured hepatocytes. Tissue Eng 5, 407, 1999.
46. Wake, M.C., Patrick, C.W., and Mikos, A.G. Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant 3, 339, 1994.
47. Karageorgiou, V., and Kaplan, D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26, 5474, 2005.
48. Zeltinger, J., Sherwood, J.K., Graham, D.A., Müeller, R., and Griffith, L.G. Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng 7, 557, 2001.
49. Grayson, W.L., Ma, T., and Bunnell, B. Human mesenchymal stem cells tissue development in 3D PET matrices. Biotechnol Prog 20, 905, 2004.
50. Liu, H., Lin, J., and Roy, K. Effect of 3D scaffold and dynamic culture condition on the global gene expression profile of mouse embryonic stem cells. Biomaterials 27, 5978, 2006.
51. Yamamoto, M., and Tabata, Y. Tissue engineering by modulated gene delivery. Adv Drug Deliv Rev 58, 535, 2006.
52. Newman, K.D., and McBurney, M.W. Poly (D,L-lactic-coglycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells. Biomaterials 25, 5763, 2004.
53. Díez, S., and Tros de Ilarduya, C. Versatility of biodegradable poly (D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Eur J Pharm Biopharm 63, 188, 2006.
54. Richardson, S.M., Curran, J.M., Chen, R., Vaughan-Thomas, A., Hunt, J.A., Freemont, A.J., and Hoyland, J.A. The differentiation of bone marrow mesenchymal stem cells into chondrocyte-like cells on poly-L-lactic acid (PLLA) scaffolds. Biomaterials 27, 4069, 2006.
55. Crow, B.B., Borneman, A.F., Hawkins, D.L., Smith, G.M., and Nelson, K.D. Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly (D,L-lactide-co- glycolide) fibers. Tissue Eng 11, 1077, 2005.
56. Margarett, D.M.E., and Steel, J.G. Polymer surface chemistry and a novel attachment mechanism in corneal epithelial cells. J Biomed Mater Res 40, 621, 1998.
57. Ingber, D.E., Prusty, D., Sun, Z., Betensky, H., and Wang, N. Cell shape, cytoskeletal mechanics, and cell cycle control in angiogenesis. J Biomech 28, 1471, 1995.
58. Xu, S.L., and Reid, L.M. Soft, porous poly (D,L-lactide- coglycotide) microcarriers designed for ex vivo studies and for transplantation of adherent cell types including progenitors. Ann N Y Acad Sci 944, 144, 2001.
59. Ma, Z., Gao, C., Gong, Y., Ji, J., and Shen, J. Immobilization of natural macromolecules on poly-L-lactic acid membrane surface in order to improve its cytocompatibility. J Biomed Mater Res 63, 838, 2002.
60. Cui, Y.L., Hou, X., Qi, A.D., Wang, X.H., Wang, H., Cai, K.Y., Ji Yin, Y., and de Yao, K. Biomimetic surface modification of poly (L-lactic acid) with gelatin and its effects on articular chondrocytes in vitro. J Biomed Mater Res A 66, 770, 2003.
61. Silva, M.M.C.G., Cyster, L.A., Barry, J.J.A., Yang, X.B., Oreffo, R.O.C., Grant, D.M., Scotchford, C.A., Howdle, S.M., Shakesheff, K.M., and Rose, F.R.A.J. The effect of anisotropic architecture on cell and tissue infiltration into tissue engineering scaffolds. Biomaterials 27, 5909, 2006.
62. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
63. Prockop, D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71, 1997.
64. Deans, R.J., and Moseley, A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28, 875, 2000.
65. Tuan, R.S., Boland, G., and Tuli, R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5, 32, 2003.
66. Hirata, K., Tsukazaki, T., Kadowaki, A., Furukawa, K., Shibata, Y., Moriishi, T., Okubo, Y., Bessho, K., Komori, T., Mizuno, A., and Yamaguchi, A. Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2. Bone 32, 502, 2003.
67. Paek, H.J., Campaner, A.B., Kim, J.L., Golden, L., Aaron, R.K., Ciombor, D.M., Morgan, J.R., and Lysaght, M.J. Microencapsulated cells genetically modified to overexpress human transforming growth factor-β1: viability and functionality in allogeneic and xenogeneic implant models. Tissue Eng 12, 1733, 2006.
68. Cao, L., Liu, L., Chen, Z.Y., Wang, L.M., Ye, J.L., Qiu, H.Y., Lu, C. L., and He, C. Olfactory ensheathing cells genetically modified to secrete GDNF to promote spinal cord repair. Brain 127, 535, 2004.